Patents Assigned to EPICENTRIX, INC.
  • Treatment of gliomas using organonitro compound combination therapy
    Patent number: 9987270
    Abstract: The invention provides therapeutic methods and kits for treating a glioma using a particular dosing regimen of the organonitro compound ABDNAZ, radiation therapy, and one of temozolomide, irinotecan, or bevacizumab.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: June 5, 2018
    Assignee: EPICENTRIX, INC.
    Inventors: Bryan T. Oronsky, Jan Scicinski